Programmed death‐ligand 1 immunoexpression in matched biopsy and liquid‐based cytology samples of advanced stage non‐small cell lung carcinomas
Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) is essential in patients of advanced non-small-cell lung cancer to determine eligibility for immunotherapy. PD-L1 IHC assays have been clinically validated only on formalin-fixed paraffin-embedded tissue; however, lung cancer is frequently...
Saved in:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2018
|
| 在線閱讀: | https://doi.org/10.1111/cyt.12605 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cyt.12605 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|